16:45 , Jun 8, 2018 |  BC Week In Review  |  Financial News

On verge of global clinical trials, Just China raises $35M

Biologics company Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) raised $35 million in a series B plus round led by Hillhouse Capital. Existing investors Temasek, Lilly Asia Ventures, Arch Venture Partners, Taikang and BOCGI Zheshang Capital...
19:26 , Jun 6, 2018 |  BC Extra  |  Financial News

Just China raises $35M ahead of global trials

Biologics company Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) raised $35 million in a series B plus round led by Hillhouse Capital. Existing investors Temasek, Lilly Asia Ventures, Arch Venture Partners, Taikang and BOCGI Zheshang Capital...